Momento de la cirugía en pacientes iraquíes con Contagio de COVID-19 / Timing of surgery in Iraqi patients with COVID-19 infection

Los pacientes con infección perioperatoria por COVID-19 tienen un alto riesgo de muerte y complicaciones posoperatorias. En la actualidad, la infección por COVID-19 en Irak representó 1.696.390 casos con 19.087 muertes. Un estudio nacional, único y observacional que incluyó pacientes con infección por COVID-19 que se sometieron a cualquier tipo de cirugía en el Hospital General de Abu-Graib, Bagdad, Irak, durante el período del 19 de marzo de 2020 al 30 de abril de 2021. Tiempo desde el diagnóstico de la infección por COVID-19 El día de la cirugía se recogió como factor categórico dividido en: (a) 0-3 semanas; (b) 4­6 semanas; (c) >6 semanas. Edad; sexo; estado físico de la Sociedad Americana de Anestesiólogos (ASA); comorbilidades cardíacas; comorbilidades respiratorias; indicación de cirugía; grado de cirugía; y se documentaron los tipos quirúrgicos. Se incluyeron un total de 378 pacientes con una edad media de 47,89±16,03 años. Las mujeres eran más que los hombres (65,87% > 34,13%). Aproximadamente, el 76,72% de los pacientes pertenecían a ASA I-II, mientras que el 23,28% eran ASA III-IV. Alrededor del 19,05% de los pacientes sufría de comorbilidades cardíacas. 266/378 de los pacientes se quejaron de comorbilidades respiratorias. Cirugía indicada en 35,45% condiciones benignas, 27,5% obstetricia, 7,65% cirugía oncológica y 29,4% operaciones traumáticas. Operaciones mayores documentadas en 205/378 pacientes. Las intervenciones quirúrgicas de urgencia realizadas en (176, 46,56%), mientras que los casos electivos fueron 202/378 (53,44%). En total, en el momento de la operación, 80 (21,16 %) pacientes tenían un diagnóstico preoperatorio de COVID-19. El tiempo desde el diagnóstico de COVID-19 hasta la cirugía fue de 0 a 3 semanas en 98 pacientes (25,93 %), de 4 a 6 semanas en 115 pacientes (30,42 %) y >6 semanas en 165 pacientes (43,65 %). La tasa de mortalidad postoperatoria global fue del 9,52% (36/378). Con respecto a la complicación cardiaca de la O.P., no hubo asociación significativa en relación al momento previo a la cirugía (p=0,08). Sin embargo, la complicación cardíaca global fue del 16,4%. En general, el 44,97 % (170/378) de los pacientes desarrollaron una complicación pulmonar por O.P. durante el período de seguimiento. Hasta donde sabemos, este es el primer estudio que proporciona datos sólidos sobre el momento óptimo para la cirugía después de la infección por COVID-19 en Irak. El momento óptimo de la cirugía después de la infección por COVID-19 fue de más de 6 semanas. Descubrimos que los riesgos de morbilidad y mortalidad por O.P. son mayores si los pacientes son operados dentro de las 6 semanas posteriores al diagnóstico de infección por COVID-19.

Patients with perioperative COVID-19 infection are at high risk of death and complications postoperatively. Nowadays, COVID-19 infection in Iraq accounted 1,696,390 cases with 19,087 deaths. A national, single, and observational study that included patients with COVID-19 infection undergoing any type of surgery in Abu-Graib General Hospital, Baghdad Iraq during period from 19 March 2020 to 30 April 2021. Time from the diagnosis of COVID-19 infection to day of surgery was collected as a categorical factor divided into: (a) 0­3 wks; (b) 4­6 wks; (c) >6 wks. Age; sex; American Society of Anesthesiologists (ASA) physical status; cardiac comorbidities; respiratory comorbidities; indication for surgery; surgery grade; and surgical types were documented. A total of 378 patient were included with mean age was 47.89±16.03 years. Females were more than males (65.87% > 34.13%). Approximately, 76.72% of patients belonged within ASA I-II, whereas 23.28% were ASA III-IV. About 19.05% of patients suffered from cardiac comorbidities. 266/378 of patients complained from respiratory comorbidities. Surgery indicated in 35.45% benign conditions, 27.5% obstetrics, 7.65% oncological surgery, and 29.4% traumatic operations. Major operations documented in 205/378 patients. Emergencies surgical intervention done in (176, 46.56%), whereas elective cases were 202/378 (53.44%). In total at operation timing, 80(21.16%) patients had a preoperative COVID-19 diagnosis. The time from COVID-19 diagnosis to surgery was 0­3 weeks in 98 patients (25.93%), 4­6 weeks in 115 patients (30.42%), and >6 weeks in 165 patients (43.65%). The overall postoperative mortality rate was 9.52% (36/378). In regard to P. O. cardiac complication, there was no significant association in relation to timing before surgery (p=0.08). However, the overall cardiac complication was 16.4%. Overall, 44.97% (170/378) of patients developed a P. O. pulmonary complication within period of follow-up. To our knowledge this is the first study to provide strong data regarding the optimal timing for surgery following COVID-19 infection in Iraq. The optimal timing of surgery after COVID-19 infection was more than 6 wks. We found that risks of P. O. morbidity and mortality are greatest if patients are operated within 6 wks of diagnosis of COVID-19 infection

Intervención educativa en el nivel de conocimientos de adultos mayores cardiópatas sobre covid-19 / Educational intervention at the level of knowledge of cardiopathic elder people on COVID-19

RESUMEN Introducción: los sistemas sanitarios de la mayoría de los países, responden a la pandemia de enfermedad respiratoria aguda (covid-19) causada por el virus SARS-CoV-2. Esta se presenta de forma más severa en adultos mayores y, sobre todo, en aquellos que padecen otras patologías. Objetivo: evaluar la efectividad de una intervención educativa en el nivel de conocimientos de adultos mayores cardiópatas sobre covid-19. Materiales y métodos: se realizó un estudio cuasiexperimental sin grupo control, de tipo intervención comunitaria, en adultos mayores cardiópatas pertenecientes al Consultorio Médico de la Familia 1, del Policlínico Docente Francisca Rivero Arocha, del municipio Manzanillo, en Granma, entre abril y junio de 2020. Se trabajó con una población de 108 adultos mayores y una muestra de 98 pacientes. Se calcularon las frecuencias absolutas y relativas. Para las variables cualitativas se aplicó la prueba de chi cuadrado. Para comparar los datos antes y después de la intervención, se empleó el test de McNemar, con nivel de significación del 5 %. Resultados: predominó el sexo femenino y los pacientes entre 60 y 69 años. Prevaleció la hipertensión y la cardiopatía isquémica. La mayoría de los pacientes mostró un nivel inadecuado de conocimientos sobre generalidades de la covid-19, lo que se logró reducir. Se incrementó el nivel de conocimientos adecuados en los adultos mayores cardiópatas sobre epidemiología, aspectos clínicos y medidas de protección y autocuidado. Conclusiones: la intervención educativa permitió modificar los conocimientos de adultos mayores cardiópatas sobre el nuevo coronavirus, pero aún es necesario el trabajo con la información de todo lo relacionado con la covid-19 (AU).

ABSTRACT Introduction: the health systems of most of the countries are facing the pandemic of the acute respiratory disease (COVID-19) caused by SARS-CoV-2 virus. It occurs in a more acute way in elder people and, above all, in those affected by other pathologies. Objective: to assess the effectiveness of an educational intervention at the level of knowledge of cardiopathic elder people on COVID-19. Materials and methods: a quasi-experimental, community-intervention type study without control group was carried out in cardiopathic elder people belonging to the Family Physician Office 1, of the polyclinic Francisco Rivero Arocha, of the Manzanillo municipality, province of Granma, in the period April-June 2020. We worked with a population of 108 elder people and a sample of 98 patients. Absolute and relative frequencies were worked out. The chi-square test was used for qualitative variables. To compare data before and after intervention, the McNemar test was used, with a significance level of 5 %. Results: female sex and patients aged 60-69 years. Hypertension and ischemic heart disease prevailed. Most of patients showed an inadequate level of knowledge on COVID-19 generalities, a fact that was reduced at the end. The adequate level of knowledge of cardiopathic elder people on epidemiology, clinical aspects and protection and self-care measures was increased. Conclusions: the educational intervention allowed modifying the knowledge of cardiopathic elder people on the novel coronavirus, but it is still necessary to work on the information of everything related to COVID-19 (AU).

Mortalidad por COVID-19 y diagnóstico tardío en las primeras etapas de la pandemia en Bolívar-Colombia / Mortality from COVID-19 and late diagnosis in the early stages of the pandemic in Bolívar-Colombia

Introducción: Los pacientes fallecidos por COVID-19 al inicio de la pandemia evidencian características clínico-epidemiológicas particulares y su identificación, lo mismo que los aspectos asociados a su diagnóstico son fundamentales para la implementación de estrategias en salud pública que permitan la protección sanitaria de los grupos más vulnerables. Objetivo: Determinar las características clínico epidemiológicas de los pacientes fallecidos por COVID-19 y su asociación con el diagnóstico tardío en las primeras etapas de la pandemia en el departamento de Bolívar-Colombia. Materiales y Métodos: Estudio descriptivo de corte transversal con una muestra de 51 pacientes fallecidos por COVID-19; se calculó la frecuencia relativa de los factores de riesgo clínico epidemiológicos de estos pacientes y se realizó un análisis bivariado para evidenciar la asociación con la posibilidad de ser diagnosticado después de la muerte, usando la razón de disparidad (OR) con su intervalo de confianza Resultados: El 47,2 por ciento de los diagnósticos se hicieron después de la muerte; el promedio entre el inicio de los síntomas y la muerte fue aproximadamente 13 días, en los que se evidencia como comorbilidades importantes las enfermedades cardíacas (58,5 por ciento) y la hipertensión (35,8 por ciento). La asociación con el diagnóstico después de la muerte se relaciona con los casos notificados en abril y mayo (p=0,03), ser mayor de 80 años (p=0,03) y tener malnutrición (p=0,04). Conclusión: En el contexto del departamento de Bolívar se observan fallas en el diagnóstico oportuno de algunos grupos poblacionales vulnerables y a los pacientes con enfermedades cardíacas se debe prestar atención para evitar la alta mortalidad(AU)

Introduction: Patients who died from COVID-19 at the beginning of the pandemic show particular clinical-epidemiological characteristics and their identification as well as the aspects associated with the diagnosis are fundamental for the implementation of public health strategies that allow the sanitary protection of the most vulnerable groups. Objective: To determine the clinical-epidemiological characteristics of patients who died from COVID-19 and its association with late diagnosis in the early stages of the pandemic in the department of Bolívar-Colombia. Material and Methods: Descriptive cross-sectional study with a sample of 51 patients who died from COVID-19; the relative frequency of the clinical-epidemiological risk factors of these patients was calculated and a bivariate analysis was performed to show the association with the possibility of being diagnosed after death, using the disparity ratio (OR) with its confidence interval. Results: The 47,2 percent of the diagnoses were made after death; the average between the onset of symptoms and death was approximately 13 days, in which heart disease (58,5 percent) and hypertension (35,8 percent) were evidenced as important comorbidities. The association with diagnosis after death is related to the cases reported in April and May (p = 0.03), being older than 80 years (p = 0.03) and having malnutrition (p = 0.04). Conclusion: In the context of the department of Bolívar, failures are observed in the timely diagnosis of some vulnerable population groups, thus special attention should be paid to patients with heart disease to avoid high mortality(AU)

Clinical and immunological characteristics of patients with anti-synthetase syndrome complicated with cardiac involvement / 北京大学学报(医学版)

OBJECTIVE@#To investigate the clinical and immunological features of cardiac involvement in patients with anti-synthetase syndrome (ASS).@*METHODS@#In the study, 96 patients diagnosed with ASS hospitalized in the Department of Rheumatology and Immunology, Peking University People's Hospital from April 2003 to November 2020 were included. The patients were divided into two groups according to whether they were accompanied with cardiac involvement. Demographic features, clinical characteristics (Gottron's sign/papules, muscle damage, etc.), comorbidities, laboratory indices (creatine kinase, inflammatory indicators, immunoglobulin, complement, lymphocyte subset, autoantibodies, etc.) were collected and the differences between the two groups were analyzed statistically.@*RESULTS@#The prevalence of cardiac involvement in the patients with ASS was 25.0% (24/96). The ASS patients complicated with cardiac involvement presented with elevated cardiac troponin I (cTnI, 75.0%, 18/24), pericardial effusion (33.3%, 8/24), reduction of left ventricular function (33.3%, 8/24) and valves regurgitation (33.3%, 8/24). The age of onset of the patients with cardiac involvement was older than that of the patients without cardiac involvement [(54.58±10.58) years vs. (48.47±13.22) years, P=0.043). Arthritis was observed less frequently in the patients with cardiac involvement than those without cardiac involvement (37.5% vs. 61.1%, P=0.044). In addition, rapidly progressive interstitial lung disease (54.2% vs. 30.6%, P=0.037) was observed more frequently in the patients with cardiac involvement than those without cardiac involvement. As compared with the ASS patients without cardiac involvement, C-reactive protein (CRP) [(13.55 (8.96, 38.35) mg/L vs. 4.60 (1.37, 17.40) mg/L, P=0.001], and lactate dehydrogenase (LDH) [408.0 (255.0, 587.0) U/L vs. 259.5 (189.8, 393.8) U/L, P=0.007] were significantly higher in the patients with cardiac involvement. Anti-Ro-52 antibody was detected more commonly in the ASS patients with cardiac involvement compared with the patients without cardiac involvement (91.7% vs. 69.4%, P=0.029). No significant differences were found in the comorbidities, alanine transaminase (ALT), aspartate transaminase (AST), creatine kinase (CK), erythrocyte sedimentation rate (ESR), ferritin (Fer), immunoglobulin G (IgG), complement 3 (C3), complement 4 (C4), lymphocyte subset between the two groups.@*CONCLUSION@#Cardiac involvement is common in ASS, mainly manifested as myocardial damage. It is necessary to be aware of cardiac complications in patients with elevated CRP, elevated LDH and positive anti-Ro-52 antibody.

Drug-related problems in cardiac neonates under intensive care / Problemas relacionados a medicamentos em neonatos cardiopatas sob terapia intensiva

ABSTRACT Objective: To determine the frequency and nature of the Drug Related Problems (DRP) in neonates with cardiac diseases admitted to an Intensive Care Unit. Methods: This prospective cross-sectional study was developed at the Neonatal Intensive Care Unit (NICU) of a teaching maternity hospital in Brazil from January 2014 to December 2016. All neonates diagnosed with any heart disease (congenital heart disease, cardiomyopathy, arrhythmias, etc.) and who were admitted to the NICU for more than 24 hours with at least one prescribed drug were included in the study. Demographic and clinical data were collected from the records of the institution's clinical pharmacy service. DRP and their respective interventions were independently reviewed and classified by two pharmacists. DRP classification was performed through the Pharmaceutical Care Network Europe v6.2 system. Results: 122 neonates were included in the study. The frequency of neonates exposed to DRP was 76.4% (confidence interval of 95% [95%CI] 65.9-82.0), with a mean of 3.2±3.8 cases/patient. In total, 390 DRP were identified, of which 49.0% were related to "treatment effectiveness", 46.7% to "adverse reactions" and 1.0% to "treatment costs". The medicines most involved in DRP were Vancomycin (10.2%; n=46), Meropenem (8.0%; n=36) and Furosemide (7.1%; n=32). Pharmacists performed 331 interventions, of which 92.1% were accepted by physicians and nurses. Conclusions: The study showed that DRP are very frequent in patients with cardiac diseases hospitalized in the NICU, predominating problems related to the effectiveness and safety of the drug treatment.

RESUMO Objetivo: Determinar a frequência e a natureza dos problemas relacionados a medicamentos (PRMs) em neonatos cardiopatas internados em uma unidade de terapia intensiva. Métodos: Trata-se de um estudo transversal prospectivo desenvolvido na Unidade de Terapia Intensiva Neonatal (UTIN) de uma maternidade de ensino do Brasil, de janeiro de 2014 a dezembro de 2016. Todos os neonatos diagnosticados com alguma doença cardíaca (cardiopatias congênitas, cardiomiopatias, arritmias etc.) e internados na UTIN por período superior a 24 horas, com pelo menos um medicamento prescrito, foram incluídos no estudo. Dados demográficos e clínicos foram coletados a partir dos registros do serviço de farmácia clínica da instituição. Os PRMs e suas respectivas intervenções foram revisadas e classificadas independentemente por dois farmacêuticos. A classificação dos PRMs foi realizada por meio do sistema Pharmaceutical Care Network Europe versão 6.2. Resultados: Cento e vinte e dois neonatos foram incluídos no estudo. A frequência de neonatos expostos a PRM foi de 76,4% (intervalo de confiança de 95% [IC95%] 65,9-82,0), com média de 3,2±3,8 casos por paciente. Ao todo, 390 PRM foram identificados, sendo que 49,0% estiveram relacionados à "efetividade do tratamento", 46,7% a "reações adversas" e 1,0% a "custos do tratamento". Os medicamentos mais envolvidos em PRM foram: vancomicina (10,2%; n=46), meropenem (8,0%; n=36) e furosemida (7,1%; n=32). Os farmacêuticos realizaram 331 intervenções, sendo 92,1% aceitas por médicos e enfermeiros. Conclusões: O estudo mostrou que PRMs são muito frequentes em pacientes cardiopatas internados em UTIN, predominando problemas relacionados à efetividade e segurança do tratamento medicamentoso.

Prevalência de nefropatia induzida por contraste em pacientes cardíacos de um setor de hemodinâmica / Prevalence of contrast-induced nephropathy in cardiac patients in a hemodynamic sector / Prevalencia de nefropatía inducida por contraste en pacientes cardíacos de un sector de hemodinámica

Objetivo: Determinar a prevalência da nefropatia induzida por contraste em pacientes cardiopatas submetidos a procedimentos angiográficos de diagnóstico e/ou tratamento. Método: Estudo prospectivo, quantitativo, realizado no setor de hemodinâmica de um hospital de grande porte, situado na região norte do Rio Grande do Sul, Brasil. A amostra foi constituída por 79 participantes através do cálculo de tamanho amostral. Resultados: A amostra foi formada por 52 (65,8%) homens e 27 (34,2%) mulheres. A idade média foi de 65,9 ± 9,52 anos. A incidência de nefropatia induzida por contraste foi de 30,38%, totalizando 24 pacientes. Conclusão: Foi evidenciada uma alta prevalência de nefropatia por contraste, apesar dos pacientes apresentarem poucos fatores de risco, o que ressalta a necessidade de medidas preventivas e redução do volume de contraste

Objective: To determine the prevalence of contrast-induced nephropathy in cardiac patients undergoing diagnostic and / or treatment angiographic procedures. Method: A prospective, quantitative study in the hemodynamics sector of a large hospital, located in the northern region of Rio Grande do Sul, Brazil. The sample consisted of 79 participants through the calculation of sample size. Results: The sample consisted of 52 (65.8%) men and 27 (34.2%) women. The mean age was 65.9 ± 9.52 years. The incidence of contrast-induced nephropathy was 30,38%, totaling 24 patients. Conclusion: A high prevalence of contrast nephropathy was evidenced, despite the fact that patients presented few risk factors, which highlights the need for preventive measures and reduction of contrast volume

Objetivo: Determinar la prevalencia de la nefropatía inducida por contraste en pacientes cardiopatas sometidos a procedimientos angiográficos de diagnóstico y / o tratamiento. Método: Estudio prospectivo, cuantitativo, realizado en el sector de hemodinámica de un hospital de gran porte, situado en la región norte de Rio Grande do Sul, Brasil. La muestra fue constituida por 79 participantes a través del cálculo de tamaño muestral. Resultados: La muestra fue formada por 52 (65,8%) hombres y 27 (34,2%) mujeres. La edad media fue de 65,9 ± 9,52 años. La incidencia de nefropatía inducida por contraste fue del 30,38%, totalizando 24 pacientes. Conclusión: Se evidenció una alta prevalencia de nefropatía por contraste, a pesar de que los pacientes presentaban pocos factores de riesgo, lo que resalta la necesidad de medidas preventivas y reducción del volumen de contraste

Fatores de risco relacionados à mortalidade em pacientes internados por Doença Arterial Periférica / Risk Factors related to patients hospitalized for Peripheral Arterial Disease

Introdução: Pacientes portadores de vasculopatia periférica internam recorrentemente para procedimentos cirúrgicos ou tratamento clínico devido a complicações da doença de base. O real impacto da desnutrição nesses pacientes durante a internação ainda é pouco compreendido. Objetivo: Investigar os fatores de risco associados à mortalidade em pacientes internados com doença vascular periférica devido a complicação da doença vascular. Métodos: Estudo observacional retrospectivo avaliou cento e dezessete pacientes acima de 18 anos admitidos no serviço de cirurgia vascular de hospital terciário no período de junho de 2013 a agosto de 2014 por complicação da doença vascular. Avaliados parâmetros clínicos, comorbidades, dados demográficos, complicações durante a internação e estado nutricional. Dados coletados por meio de entrevista, aplicação do questionário Avaliação Global Subjetiva (AGS), exame físico e laboratoriais e dados de prontuário. Resultados: Cento e dezessete pacientes com doença vascular periférica avaliados em relação a complicações vasculares durante internação. Mortalidade geral de 7,7% e pacientes desnutridos ou com suspeita de desnutrição eram 39% da amostra Através da análise multivariada, tanto a classificação AGS (OR 6,15 CI 1,092-34,74 P = 0,039) quanto a presença de doença cardíaca (OR 8,51 CI 1,56-47,44 P = 0,015) foram fatores preditores independentes para mortalidade. Pacientes com doença vascular classificados em suspeita de estarem desnutridos ou desnutridos apresentaram chance de ir a óbito durante a internação aumentada em 6,15 vezes, enquanto a cardiopatia elevou essa chance 8,51 vezes. Conclusão: Pacientes internados por complicação de doença vascular periférica apresentam como fatores de risco para mortalidade a desnutrição e a presença de doença cardíaca.(AU)

Patients with peripheral vasculopathy are routinely hospitalized for surgical procedures or clinical treatment due to complications of the underlying disease. The real impact of malnutrition in these patients during hospitalization is still poorly understood. Aim: This study aimed to assess mortality predictors in patients with peripheral vascular disease during hospitalization. Methods: This retrospective observational study evaluate one hundred and seventeen patients over 18 years admitted to the vascular surgery service of a tertiary hospital in the period of June 2013 and August 2014 due to complications of vascular disease. They were assessed for clinical parameters, comorbidities, demographics, complications during hospitalization and nutritional status. Data were collected through interviews, the questionnaire Subjective Global Nutritional Assessment (SGA), laboratory exam and physical examination. Results: One hundred and seventeen patients with peripheral vascular disease were followed during admission due to vascular complications. Overall mortality was 7.7%, and malnourished patients or patients at nutritional risk were 39,0% of the sampled population By multivariate analysis both rating by SGA (OR 6.15, CI 1.092 to 34.74, P = 0.039), the presence of heart disease (OR 8.51 CI 1,56 to 47.44 P = 0.015) were independent predictors of mortality. When the patient was classified as malnourished or suspected of being malnourished by SGA it increased 6.15 times the odds of death during hospitalization, while the presence of heart disease increased by 8.51 times. Conclusion: Patients hospitalized for complications of peripheral vascular disease present as risk factors for mortality: malnutrition and the presence of heart disease. (AU)

Pulmonary Hypertension in General Cardiology Practice / Hipertensão Pulmonar na Prática do Cardiologista

Abstract The finding of pulmonary hypertension (PH) by echocardiography is common and of concern. However, echocardiography is just a suggestive and non-diagnostic assessment of PH. When direct involvement of pulmonary circulation is suspected, invasive hemodynamic monitoring is recommended to establish the diagnosis. This assessent provides, in addition to the diagnostic confirmation, the correct identification of the vascular territory predominantly involved (arterial pulmonary or postcapillary). Treatment with specific medication for PH (phosphodiesterase type 5 inhibitors, endothelin receptor antagonists and prostacyclin analogues) has been proven effective in patients with pulmonary arterial hypertension, but its use in patients with PH due to left heart disease can even be damaging. In this review, we discuss the diagnosis criteria, how etiological investigation should be carried out, the clinical classification and, finally, the therapeutic recommendations for PH.

Resumo O achado de hipertensão pulmonar (HP) em avaliação ecocardiográfica é frequente e preocupante. No entanto, o ecocardiograma é apenas um exame sugestivo e não diagnóstico de HP. Quando se suspeita de acometimento direto da circulação pulmonar, está indicada medida hemodinâmica invasiva para estabelecer o diagnóstico. Essa avaliação permite, além da confirmação diagnóstica, a correta identificação do território vascular predominantemente acometido (arterial pulmonar ou pós-capilar). O tratamento com as medicações específicas de HP (inibidores da fosfodiestarese 5, antagonistas do receptor de endotelina, análogos da prostaciclina e estimulador da guanilil ciclase solúvel) é comprovadamente eficaz para pacientes com hipertensão arterial pulmonar, mas seu uso em pacientes com HP decorrente de doença cardíaca de câmaras esquerdas pode até mesmo ser prejudicial. Discutiremos nesta revisão o critério diagnóstico, a maneira de proceder a investigação etiológica, a classificação clínica e, finalmente, as recomendações terapêuticas na HP.

Recomendações da prática de enfermagem no manejo de anticoagulantes em unidade hospitalar: um direcionamento para o cuidado / Recommendations for nursing practice in the management of anticoagulants in a hospital unit: a guide for care

Introdução: Os anticoagulantes estão inseridos na classe de medicamentos com alto risco de eventos adversos e de acordo com suas características exigem extremo cuidado no seu manuseio. Nesse contexto, o enfermeiro torna-se fundamental no gerenciamento clínico aos pacientes em uso de anticoagulantes, com o objetivo do planejamento necessário para seu tratamento, acompanhamento e uso adequado de recursos no ambiente hospitalar. Objetivo Geral: discutir a prática de Enfermagem no cuidado aos pacientes cardiovasculares em uso de anticoagulantes em unidade hospitalar. Específicos: identificar as características epidemiológicas e clínicas dos pacientes cardiovasculares que utilizam anticoagulantes em unidade hospitalar, discutir as boas práticas de enfermagem relacionadas à anticoagulação de pacientes cardiovasculares em uso de anticoagulantes em unidade hospitalar e propor estratégias para o manejo de Enfermagem no cuidado aos pacientes cardiovasculares em uso de anticoagulantes em unidade hospitalar. Metodologia: Trata-se de um estudo com abordagem qualitativa. A obtenção dos dados foi mediante análise documental de prontuários através de um roteiro estruturado dos pacientes cardiovasculares que fizeram uso de alguma categoria anticoagulante durante a internação hospitalar. Foi realizada busca e estratificação em bases de dados de evidências científicas além de realização de entrevistas semiestruturadas aos enfermeiros de um hospital privado situado na cidade do Rio de Janeiro. Resultados: Quanto às características dos enfermeiros entrevistados, houve diferença significativa entres os sexos, sendo 78% (67) para o sexo feminino e 22% (19) para o sexo masculino. O número mais representativo de enfermeiros (29) esteve concentrado nos Centros de Terapia Intensiva. Quanto ao perfil dos prontuários de pacientes analisados, não houve diferença significativa entres os sexos embora o sexo feminino seja mais prevalente. A média de idade foi de 67,4 anos e o tempo médio de internação dos pacientes foi de 6 dias. Grande parte dos clientes tinha mais de duas comorbidades. Foi possível evidenciar práticas clínicas de enfermagem em relação aos anticoagulantes orais e subcutâneos. Os prontuários evidenciaram monitoramento laboratorial dos pacientes em uso desta classe medicamentosa com a observação de coleta de exame para analisar o fator anti-Xa. Quanto aos anticoagulantes intravenosos foi possível observar que os enfermeiros possuem autonomia para controlarem protocolo de heparinização venosa, realizando cálculos de dosagem para início e manutenção da terapia 97% (32), administram o anticoagulante em via exclusiva 91% (30), utilizam cateteres venosos mais calibrosos 85% (28), realizam monitoramento laboratorial 100% (33), através do Tempo de Tromboplastina Parcial ativado a cada 6 horas. E obtivemos resultados em relação a orientações aos pacientes e familiares quanto os principais riscos desta terapia, sangramentos e surgimento de hematomas. Conclusão: Destaca-se a importância dos enfermeiros na assistência qualificada, integral e individualizada à pacientes em uso de anticoagulantes, enfatizando a relevância do cuidado seguro e qualificado para a melhoria das condições de saúde do indivíduo.

Introduction: Anticoagulants are included in the class of drugs with a high risk of adverse events and, according to their characteristics, require extreme care in their handling. In this context, nurses become fundamental in the clinical management of patients using anticoagulants, with the objective of planning necessary for their treatment, monitoring and adequate use of resources in the hospital environment. General Objective: to discuss the Nursing practice in the care of cardiovascular patients using anticoagulants in a hospital unit. Specific: to identify the epidemiological and clinical characteristics of cardiovascular patients using anticoagulants in a hospital unit, discuss good nursing practices related to anticoagulation of cardiovascular patients using anticoagulants in a hospital unit and propose strategies for Nursing management in the care of cardiovascular patients in use of anticoagulants in a hospital unit. Methodology: This is a study with a qualitative approach. Data collection was performed through documental analysis of medical records through a structured script of cardiovascular patients who used some anticoagulant category during hospital stay. A search and stratification of scientific evidence databases was carried out, as well as semi-structured interviews with nurses from a private hospital located in the city of Rio de Janeiro. Results: Regarding the characteristics of the nurses interviewed, there was a significant difference between the sexes, with 78% (67) for females and 22% (19) for males. The most representative number of nurses (29) was concentrated in the Intensive Care Centers. Regarding the profile of the medical records of the analyzed patients, there was no significant difference between the sexes, although females are more prevalent. The mean age was 67.4 years and the mean length of hospital stay for patients was 6 days. Most of the clients had more than two comorbidities. It was possible to evidence clinical nursing practices in relation to oral and subcutaneous anticoagulants. The medical records showed laboratory monitoring of patients using this drug class with the observation of exam collection to analyze the anti-Xa factor. Regarding intravenous anticoagulants, it was possible to observe that nurses have autonomy to control venous heparinization protocol, performing dosage calculations for initiation and maintenance of therapy 97% (32), administer the anticoagulant exclusively 91% (30), use venous catheters more caliber 85% (28), carry out laboratory monitoring 100% (33), through activated Partial Thromboplastin Time every 6 hours. And we obtained results in relation to guidelines for patients and families regarding the main risks of this therapy, bleeding and the appearance of hematomas. Conclusion: The importance of nurses in qualified, comprehensive and individualized care for patients using anticoagulants is highlighted, emphasizing the importance of safe and qualified care for the improvement of the individual's health conditions.

Factores de riesgo asociados a complicaciones anestésicas en enfermos renales crónicos intervenidos de urgencia / Risk factors associated with anesthetic complications in chronic renal patients undergoing emergency surgery

INTRODUCTION: Chronic kidney disease is a clinical entity secondary to the common final pathway of multiple etiologies with risk factors common to other chronic diseases. OBJECTIVE: To identify the risk factors related to the appearance of anesthetic complications in chronic renal patients undergoing emergency surgery. METHOD: A prospective cohort study was performed in patients with chronic kidney disease undergoing emergency surgery. The exposed cohort consisted of 15 patients with chronic kidney disease who developed complications during the study period. RESULTS: Age over 40 years, patients with ischemic heart disease and hypertensive patients presented a higher risk of anesthetic complications. Obesity and bronchial asthma were no risk factors. It was demonstrated that when the time elapsed between hemodialysis and the operation was less than 2 hours, the risk of anesthetic complications increased, the stage of the disease and the associated drugs were not related to the appearance of complications. Patients who received general anesthesia had three times more risk of complications than those under regional anesthesia. CONCLUSIONS: Age, arterial hypertension, ischemic heart disease, heart failure and the use of general anesthesia are risk factors associated with complications.

INTRODUCCIÓN: La enfermedad renal crónica es una entidad clínica secundaria a la vía final común de múltiples etiologías con factores de riesgo comunes a otras enfermedades crónicas. OBJETIVO: Identificar los factores de riesgo relacionados con la aparición de complicaciones anestésicas en enfermos renales crónicos intervenidos de urgencia. MÉTODO: Se realizó un estudio de cohorte prospectivo en pacientes con enfermedad renal crónica intervenidos por cirugía general de urgencia. La cohorte expuesta estuvo constituida por 15 pacientes con enfermedad renal crónica que desarrollaron complicaciones en el período en estudio. RESULTADOS: La edad mayor o igual a 40 años, los pacientes con cardiopatía isquémica y los hipertensos presentaron mayor riesgo de complicaciones anestésicas, no así la obesidad al igual que el asma bronquial. Se demostró que cuando el tiempo transcurrido entre la hemodiálisis y la operación fue inferior a 2 horas se incrementó el riesgo de complicaciones anestésicas, el estadio de la enfermedad y los medicamentos asociados no estuvieron relacionados con la aparición de complicaciones. Los pacientes a los que se administró anestesia general tuvieron tres veces más riesgo de complicaciones que aquellos que fueron intervenidos con anestesia regional. CONCLUSIONES: La edad, la hipertensión arterial, la cardiopatía isquémica, la insuficiencia cardiaca y el empleo de anestesia general son factores de riesgo asociados a complicaciones, en los pacientes portadores de IRC, sometidos a cirugía de urgencia.

Cardiovascular Manifestations of Erdheim-Chester's Disease: A Case Series / Manifestações Cardiovasculares da Doença de Erdheim-Chester: Uma série de Casos

Abstract Erdheim-Chester Disease is a rare entity, classified as an inflammatory myeloid neoplasm, with an unknown incidence, occurring preferentially in men after 50 years of age. Classically, it has a multisystemic presentation, with the skeletal system being the most frequently affected (90% of the patients), followed by genitourinary involvement in 60% of cases and central nervous system in the pituitary and diabetes insipidus in 25% of the cases. Cardiovascular manifestations are present in more than half of the patients, with aortic infiltration and atrial pseudotumor being the most common forms.

Resumo A doença de Erdheim-Chester é uma entidade rara classificada como neoplasia mielóide inflamatória, com incidência desconhecida que ocorre preferencialmente em homens após os 50 anos de idade. Classicamente apresenta-se de forma multissistêmica, sendo sistema esquelético o mais frequentemente comprometido (90% dos pacientes), seguido do sistema geniturinário em 60% dos casos e sistema nervoso central em hipófise e diabetes insipidus em 25% dos casos. As manifestações cardiovasculares estão presentes em mais da metade dos pacientes, sendo a infiltração da aorta e o pseudotumor atrial as formas mais encontradas.

The cardiopulmonary bypass and cancer dissemination puzzle

Abstract Early cancer diagnosis, new therapies that increased survival of patients, besides the increasingly elderly population are some factors would be associated with possible cancer dissemination in patients under cardiopulmonary bypass (CPB) cardiac surgery. Also, the benefits, and risks, regarding long-term survival, have not yet been established. Therefore, cardiac surgery morbimortality may be superior in patients with cancer disease. Also, immunologic and inflammatory changes secondary to CPB can also increase tumor recurrence. After a brief introduction and CPB immunologic the two main topic subjects included: 1) Combined heart surgery and lung resection and; 2) Possible influence of neoplasia type. After observing the relative literature scarcity, we keep the opinion that "CPB has a modest association with cancer progression" and that "CPB and cancer dissemination should be a logical but unlikely association."